Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Guelph

$30,000.00

Molecular identification and control of apicomplexan parasites

EF 2012-13

Résumé
Many of apicomplexan parasites (such as malaria, Toxoplasma and coccidia) are of serious veterinary, agricultural and medical importance. Eimeria are continuing and serious challenges to profitable rearing of commercial poultry (especially chickens). Medication costs and production losses from coccidiosis cost the poultry industry several $100 million each year in Canada. Live vaccines against coccidia are possible but are complicated by immunologically distinct strains of many Eimeria species. We have distinct lines of E. maxima that are similar to one another but do not cross-immunize birds (they do not protect against challenge with the second strain despite their similarity). The few differences that exist between these E. maxima strains must be important targets of a protective immune response. We have determined the window of development of the parasite that is susceptible to control. We propose to conduct a highly detailed molecular dissection of these two parasite strains using transcriptome analysis of these parasites during the time when immunologically relevant molecules are being produced by the parasites. We will examine any differences found for immunological relevance and, when the possible candidate molecules have been identified, vaccination candidates (live vaccines carried by non-pathogenic Salmonella/Bacillus species or via plasmid-based DNA vaccination). This exciting work is the culmination of a long period of research into the interactions that exist between these economically and medically important parasites and their vertebrate hosts. ) To further aid in the control of these parasites, we intend to use our expanding collection of molecular markers for the various parasites to develop molecular methods of identifying and quantifying parasites in tissue and/or feces of infected chickens. We will use DNA barcoding methods to first identify and characterize each species that infects birds (and then other animals) and then develop specific probes that can be used in high throughput RT-PCR equipment to give precise numbers of parasites of each species in diagnostically relevant samples such as feces, blood or tissues to aid in control of these parasites.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
106453-2011
Name nom
Barta, John
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5304
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular evolution
Research subject fr
Évolution moléculaire
Partie
2
Nb partie
5
Application title
Molecular identification and control of apicomplexan parasites
Keyword
NSERC
Application summary
Many of apicomplexan parasites (such as malaria, Toxoplasma and coccidia) are of serious veterinary, agricultural and medical importance. Eimeria are continuing and serious challenges to profitable rearing of commercial poultry (especially chickens). Medication costs and production losses from coccidiosis cost the poultry industry several $100 million each year in Canada. Live vaccines against coccidia are possible but are complicated by immunologically distinct strains of many Eimeria species. We have distinct lines of E. maxima that are similar to one another but do not cross-immunize birds (they do not protect against challenge with the second strain despite their similarity). The few differences that exist between these E. maxima strains must be important targets of a protective immune response. We have determined the window of development of the parasite that is susceptible to control. We propose to conduct a highly detailed molecular dissection of these two parasite strains using transcriptome analysis of these parasites during the time when immunologically relevant molecules are being produced by the parasites. We will examine any differences found for immunological relevance and, when the possible candidate molecules have been identified, vaccination candidates (live vaccines carried by non-pathogenic Salmonella/Bacillus species or via plasmid-based DNA vaccination). This exciting work is the culmination of a long period of research into the interactions that exist between these economically and medically important parasites and their vertebrate hosts. ) To further aid in the control of these parasites, we intend to use our expanding collection of molecular markers for the various parasites to develop molecular methods of identifying and quantifying parasites in tissue and/or feces of infected chickens. We will use DNA barcoding methods to first identify and characterize each species that infects birds (and then other animals) and then develop specific probes that can be used in high throughput RT-PCR equipment to give precise numbers of parasites of each species in diagnostically relevant samples such as feces, blood or tissues to aid in control of these parasites.